Growth Potential of the Disposable Medical Device Sensors Market

Download PDF  Brochure:
http://www.marketsandmarkets.com/pdfdownload.asp?id=1259

The Disposable Medical Device Sensors   market is poised to reach USD 5,936 Million by 2020, growing at a CAGR of 10.3% during the forecast period of 2015 to 2020.

 Market growth can be attributed to the growing prevalence of diabetes and other infectious diseases across the globe, government support for research and development activities in medical sensors, various benefits such as faster analysis, low costs, ease of use, and rising needs to curtail escalating healthcare costs
                                                    

Key players :
Some of the major players in this market include Medtronic plc. (Ireland), GE Healthcare (U.K.), Philips N.V. (Netherlands), Smiths Medical (U.K.), TE Connectivity (Switzerland), Freescale Semiconductors, Inc. (U.S.), Omnivision Technologies, Inc. (U.S.), STMicroelectronics (Switzerland), Analog Devices, Inc. (U.S.), and Honeywell International, Inc. (U.S.).

Geography:
The market is divided into North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa, which is further analyzed at country levels.. In addition, increasing investments in the healthcare industry by key market players, rising demand for advanced healthcare technologies, and expansion of private sector hospitals to rural areas in countries such as China, Taiwan, and India are driving the growth of this region.

Download Sample Report :
http://www.marketsandmarkets.com/requestsample.asp?id=1259

 The Disposable Medical Device Sensors   market is segmented into patient monitoring devices, diagnostic testing devices, imaging devices, and therapeutic devices. The diagnostic testing devices segment is further divided into HIV test kits, pregnancy test kits, drug and alcohol test kits, and blood glucose test strips. The therapeutic devices segment is further divided into insulin pump sensors, dialysis device sensors, cardiac therapy devices, and cardiac catheter sensors.

 The patient monitoring devices segment is categorized into continuous blood pressure monitors, pulse oximeters, cardiac monitors, continuous glucose monitoring devices, implantable loop recorders, smart pills, and others. The imaging devices segment is divided into capsule endoscopes and disposable endoscopes..

DNA Markers an Important product segment for Life science research suppliers- Asia to expect rapid growth

Molecular Weight Marker Market, by Products (DNA, RNA, Protein Ladders), by Type (Prestained, Specialty), by Application (PCR, Western Blotting, Gel Extraction), by End User (Academic Institutes, Pharmaceutical Companies, CRO) – Global Forecast to 2019

Molecular weight markers are extensively used in almost all areas of life science applications. Due to this, the adoption rate for these products is very high and is expected to increase in future.

http://www.marketsandmarkets.com/Market-Reports/molecular-weight-marker-market-117734545.html

Molecular weight markers market is a research-driven market. R&D expenditure is important indicators for this market. North America accounted for 37.74% of the global R&D spending in 2010. The U.S. alone accounted for 35.33% of all R&D spending in the world. According to estimates from the World Bank, the R&D spending in North America increased at a CAGR of 4.56% between 2001 and 2010. On the other hand, R&D spending in Asia increased from $158.94 billion in 2001 to $329.31 billion in 2010, at a CAGR of 8.43%. China has the highest growth rate for R&D spending between 2001 and 2010.

Get PDF Brochure Here :http://www.marketsandmarkets.com/pdfdownload.asp?id=117734545

The government in China is also undertaking various initiatives to promote genomics research. For instance, it is planning to invest more than $300 billion in biotechnology between 2012 and 2017. High focus on biotechnology research is another major factor driving the growth of the molecular weight markers market in Asia. Asia is growing faster in past few years and is expected to grow at the fastest rate in forecasted period. Emerging Asian countries such India, China and Japan are expected to have healthy growth in the coming five years, considering the huge R&D spending as well as growing technical know-how to increasing public funding.

The molecular weight markers in Asia expected to grow at the highest CAGR in the forecast period (2014–2019). Asian countries are expected to witness a steady year-on-year growth, due to increase in demand for innovations in proteomics and genomic research. Moreover, an increase in healthcare budgets and R&D activities in this region will further fuel the demand for molecular weight markers in this region.

The DNA is estimated to have the largest share of the molecular weight markers market in 2014. The market is expected to be driven by increased research and development spending by biotechnology companies, government and public sector funding for research. In addition, new innovations have contributed to grow the market to a great extent. The use of DNA markers will be boosted by the increasing research activities in genomics and with the advent of cheaper sequencing technologies.

To  Know More  : http://www.marketsandmarkets.com/requestsample.asp?id=117734545

The Interventional Cardiology and Peripheral Vascular Devices Market is Expected to Reach USD 31.47 Billion by 2021

“Interventional Cardiology & Peripheral Vascular Devices Market (Angioplasty Balloon, Stent, Catheters, EVAR Stent Grafts, Abdominal Aortic Aneurysm, IVC Filter, Plaque Modification, Hemodynamic Flow Alteration, Accessories, Guidewire) – Forecasts to 2021”

This report provides a detailed overview of the major drivers, restraints, challenges, opportunities, current market trends, and strategies impacting the interventional cardiology and peripheral vascular devices market, along with revenue estimates & forecasts and market share analysis.

Browse through market data tables and the in-depth ToC of the Global Interventional Cardiology and Peripheral Vascular Devices Market (2016–2021)

http://www.marketsandmarkets.com/Market-Reports/minimally-invasive-interventional-cardiology-devices-market-548.html

The global interventional cardiology and peripheral vascular devices market is expected to reach USD 31.47 billion by 2021 from USD 21.83 billion in 2016, at a CAGR of 7.1% from 2016 to 2021. Rising aging population, rising incidence of cardiovascular diseases, increasing demand of minimally invasive procedures, and technological advancements are the major factors driving the growth of this market.

On the basis of product, the interventional cardiology and peripheral vascular devices market is segmented into angioplasty balloons, angioplasty stents, catheters, EVAR stent grafts, IVC filters, plaque modification devices, hemodynamic flow alteration devices, and accessories. In 2016, the angioplasty stents segment is expected to account for the largest share of the market. High growth in this segment can be attributed to rising number of regulatory approvals, technological advancements, and increasing initiatives by companies for new product launches.

Get The PDF Brochure For This Report@

http://www.marketsandmarkets.com/pdfdownload.asp?id=548

On the basis of type, the angioplasty stent market is segmented into drug-eluting stents, bare-metal stents, and bioabsorbable stents. In 2016, the drug-eluting stents segment is expected to account for the largest share primarily due to the increasing number of regulatory approvals and technological advancements.

On the basis of type, the catheters market is segmented into IVUS/OCT, angiography catheters, and guiding catheters. In 2016, the angiography catheters segment is expected to account for the largest share of the market.

On the basis of type, the EVAR stent grafts market is segmented into abdominal aortic aneurysms and thoracic aortic aneurysms. In 2016, the abdominal aortic aneurysms segment is expected to account for the largest share primarily due to the rising incidence of smoking and hypertension.

On the basis of region, the global interventional cardiology and peripheral vascular devices market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). Asia is expected to grow at the highest CAGR during the forecast period. Growth in this regional segment is driven by factors such as the rising prevalence of cardiovascular diseases, increasing number of conferences & symposia, and increasing focus of major players on the Asian market.

Some of the major players operating in the interventional cardiology and peripheral vascular devices market are Abbott Laboratories (U.S.), Boston Scientific Corporation (U.S.), B. Braun Melsungen AG (Germany), Cordis Corporation (U.S.), C.R. Bard, Inc. (U.S.), Medtronic plc (U.S.), and Terumo Corporation (Japan).